XERS FY 2025 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$960M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$292M+43.7% YoY

Gross Profit

$238M81.7% margin

Operating Income

$25M8.5% margin

Net Income

$554,0000.2% margin

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$28M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$384M

Total Liabilities

$370M

Stockholders' Equity

$14M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$292M	$203M	+43.7%
Gross Profit	$238M	$166M	+43.4%
Operating Income	$25M	-$34M	+174.0%
Net Income	$554,000	-$55M	+101.0%